Positive Association Between Variations in CDKAL1 and Type 2 Diabetes in Han Chinese Individuals
Y. Liu,Lan Yu,Di Zhang,Zhi Chen,Daizhan Zhou,Shuangliang Zhao,S. Li,Ting Wang,Xun Hu,Feng Gao,Z. F. Zhang,Lin He,Hao Xu
DOI: https://doi.org/10.1007/s00125-008-1141-6
IF: 8.2
2008-01-01
Diabetologia
Abstract:Abbreviations IFG impaired fasting glucose IGT impaired glucose tolerance SNP single nucleotide polymorphism To the Editor: Type 2 diabetes is a complex disease that has become a rapidly growing public health problem in China. The molecular mechanisms and underlying genetic architecture of type 2 diabetes still need to be clarified. Genomewide association studies have recently described novel type 2 diabetes susceptibility loci, including several previously unknown genomic regions, such as CDKAL1 and IGF2BP2 [1–4]. Following these discoveries, a replication study has confirmed a significant association between type 2 diabetes and these two genes in the Japanese population [5]. To investigate whether variations in CDKAL1 and IGF2BP2 also play a major role in type 2 diabetes susceptibility in China, we genotyped five representative variants (rs7754840, rs10946398 and rs7756992 in CDKAL1; rs4402960 and rs1470579 in IGF2BP2) in 4,189 Han Chinese participants, including 1,912 unrelated type 2 diabetic patients (785 men, 1,127 women; age 63.8±9 years), 236 individuals with impaired fasting glucose or impaired glucose tolerance (IFG/IGT; 83 men, 153 women; age 64±9 years) and 2,041 control individuals (635 men, 1,406 women; age 58±9 years). Diabetic and IFG/IGT participants were defined in accordance with WHO criteria. Controls with a fasting plasma glucose concentration of <6.1 mmol/l were enrolled from the same region. The clinical characteristics of the participants are summarised in Table 1. The study protocol was reviewed and approved by the Ethics Committee of the Shanghai Institute for Biological Sciences and all participants gave informed consent. Highmolecular-weight genomic DNA was prepared from venous blood using the QuickGene 610L Automatic DNA/RNA Extraction System (Fijifilm, Tokyo, Japan). All five single nucleotide polymorphisms (SNPs) were genotyped using TaqMan technology on an ABI7900 system (Applied Biosystems, Foster City, CA, USA). Genotype data were Diabetologia (2008) 51:2134–2137 DOI 10.1007/s00125-008-1141-6